Chinese english Germany Japanese Korea

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Struktur
1809002-40-1
CAS-Nr.
1809002-40-1
Englisch Name:
1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Synonyma:
Tofacitinib Impurity N (Citrate);Tofacitinib Related Compound 21 Citrate;1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
CBNumber:
CB54920840
Summenformel:
C22H30N6O8
Molgewicht:
506.52
MOL-Datei:
1809002-40-1.mol
Request For Quotation

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Eigenschaften

Sicherheit

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+8618627948422
 sale@hdimpurity.com China 3681 58
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412
 3001272453@qq.com China 5158 50
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD 0755-0755-83725350 13380397412
 3001280422@qq.com China 10001 58
Molcoo Chemicals Inc. 18576690171
 3001025734@qq.com China 8880 58
PureChemland Co.,Ltd. 13540909846 13882008651
 3848291069@qq.com China 3001 58
Guangzhou Langou Biotech Co., Ltd. 15876533741
 2201851245@qq.com China 468 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 18126517264
 2850476883@qq.com China 7933 58
Hubei Moco Chemical Co., Ltd. 18627753421; 18627756402
 3001051413@qq.com China 20365 58
Cato Research Chemicals Inc. 020-81960175-877 18933936954
 2853283383@qq.com China 11421 58
Hubei Rhema Reference Materials Technology Co., Ltd. 15787875101
 645977340@qq.com China 9989 58
  • 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • Tofacitinib Impurity N (Citrate)
  • Tofacitinib Related Compound 21 Citrate
  • 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
  • 1809002-40-1
Copyright 2019 © ChemicalBook. All rights reserved